- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03132285
Safety and Acceptability Study of PrePex Device When Removing the Foreskin Shortly After Placement of Device
Safety and Acceptability Study of Non-Surgical Male Circumcision Device for Adult Male Population When Removing the Foreskin Shortly After Placement of Device Performed at Lusaka and Livingstone, Zambia
Study Overview
Detailed Description
To assess the safety and acceptability of the non-surgical PrePex device among healthy adult male participants scheduled for voluntary medical male circumcision when removing the foreskin shortly after device placement.
Five hundred (500) males scheduled for voluntary circumcision performed by clinicians or nurses using the PrePex.
Theses clinicians and nurses have already been trained in the Prepex procedure and will undergo further training in the modification to the technique. Study duration per participant will be up to 8 weeks and will include three follow up visits and one phone call follow up.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Livingstone, Zambia
- Dambwa North Clinic
-
-
Lusaka province
-
Lusaka, Lusaka province, Zambia
- Matero Main Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ages - 13 to 49 years
- Uncircumcised
- Participant wants to be circumcised
- Participant assent to the procedure
- Legal guardian consent to the procedure for ages 13-18 years
- Able to understand the study procedures and requirements
- Agrees to abstain from sexual intercourse for 8 weeks after circumcision
- Agrees to abstain from masturbation for at least 2 weeks after Removal
- Agrees to return to the health care facility for follow-up visits (or as instructed) after his circumcision for a period of 7 weeks post removal (8 weeks total)
- Participant able to comprehend and freely give informed consent for participation in this study and is considered by the investigator to have good compliance for the study
Exclusion Criteria:
- Legal guardian withholds consent for ages 13-18 years
- Active genital infection, anatomic abnormality or other condition, which in the opinion of the investigator prevents the participant from undergoing a circumcision
- Participant with the following diseases/conditions: phimosis, paraphimosis, adhesions, warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias, epispadias
- Known bleeding / coagulation abnormality, uncontrolled diabetes
- Participant that to the opinion of the investigator is not a good candidate
- Diabetes Mellitus
- HIV Sero-positive
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: PrePex Day 0 foreskin removal
Day 0 foreskin removal
|
Prepex is a non surgical male circumcision device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of incidents related to the change in procedure
Time Frame: 8 weeks
|
To assess the safety of PrePex device when removing the foreskin shortly after device placement by means of the following parameter: Incidence of Serious Adverse Events, when performed by clinicians and nurses
|
8 weeks
|
Acceptability of the changes procedure to patients
Time Frame: 8 weeks
|
To asses the new procedure acceptability for patients using the following measures - Evaluation of pain during foreskin removal
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of the change in procedure on circumcision healing time
Time Frame: 8 weeks
|
To assess the circumcision healing time period.
|
8 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 0001 (Cancer Research Institute)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Prevention
-
Prof Mags BeksinskaCompletedHIV Prevention | Pregnancy PreventionSouth Africa
-
Yale UniversityCompletedHIV Prevention | STI PreventionUnited States
-
Centers for Disease Control and PreventionUniversity of Minnesota; The Fenway Institute; AIDS Action Committee of Massachusetts and other collaboratorsCompletedHIV Prevention | STD PreventionUnited States
-
International Partnership for Microbicides, Inc.CompletedHIV PreventionSouth Africa, Uganda
-
Microbicide Trials NetworkNational Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsCompleted
-
Fenway Community HealthCompleted
-
University of California, Los AngelesUniversity of California, San Diego; California HIV/AIDS Research Program; Los... and other collaboratorsCompletedHIV PreventionUnited States
-
Microbicide Trials NetworkNational Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsCompletedHIV PreventionUganda, South Africa, Zimbabwe
-
Massachusetts General HospitalMbarara University of Science and TechnologyCompleted
-
Orion Biotechnology Polska Sp. z o.o.Scope International AGCompleted
Clinical Trials on PrePex
-
FHI 360Population Council; Population Services International; Ministry of Health, Zambia and other collaboratorsCompleted
-
Ministry of Health and Child Welfare, ZimbabweCompleted
-
Ministry of Health, RwandaCompleted
-
Nyanza Reproductive Health SocietyCompletedMale CircumcisionKenya
-
University of WashingtonCenters for Disease Control and Prevention; University of Zimbabwe; Ministry... and other collaboratorsCompleted
-
FHI 360University of Illinois at Chicago; Bill and Melinda Gates Foundation; Nyanza... and other collaboratorsCompleted
-
Ministry of Health, RwandaCompletedHIV Prevention | Male Circumcision | Screen Failure Subjects | Narrow ForeskinRwanda
-
Ministry of Health, RwandaUnknownCircumcision, AdolescentsRwanda
-
Ministry of Health, RwandaMinistry of Defence, RwandaCompletedHIV Infections | HIV Prevention | Male CircumcisionRwanda
-
Ministry of Health, RwandaCompletedHIV Prevention | Male CircumcisionRwanda